outbreak. Furthermore, it elaborates on patent-related policy options provided by the TRIPS Agreement, and WTO Members …COVID-19, caused by SARS-Cov-2, was declared to be a pandemic by the World Health Organization on 11 March 2020. Since … then, the issue of the relationship between patent protection and the development of and access to medical treatments and …

The World Trade Organisation’s (WTO) Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS … surveillance, tracking, diagnosis and treatment of COVID-19. A possible solution is a TRIPS waiver of the implementation …, application and enforcement for the prevention, containment or treatment of COVID-19. This comment addresses the ways that TRIPS …

This working paper provides a statistical analysis of 74 patent families which cover subject matter relevant to ten …), have been approved by the World Health Organization (WHO) for inclusion in its Emergency Use Listing (EUL). The analysis is … based on VaxPaL, a COVID-19 vaccines patent database developed by the Medicines Patent Pool (MPP). Through the detailed …

support national patent offices and interested parties in developing countries with information that can serve as guidance for … the examination of the claims contained in relevant patents or patent applications. The medicines considered for the … patent analysis in this report are remdesivir, ruxolitinib, favipiravir, molnupiravir and nirmatrelvir, and the …

outbreak. Furthermore, it elaborates on patent-related policy options provided by the TRIPS Agreement, and WTO Members …COVID-19, caused by SARS-Cov-2, was declared to be a pandemic by the World Health Organization on 11 March 2020. Since … then, the issue of the relationship between patent protection and the development of and access to medical treatments and …